Biodegradable pH-responsive alginate-poly (lactic-co-glycolic acid) nano/micro hydrogel matrices for oral delivery of silymarin

Carbohydrate Polymers

Volumn 83, Issue 3, 2011, Pages 1345-1354

  El Sherbiny, Ibrahim M ^a,b   Abdel Mogib, Mamdouh ^a   Dawidar, Abdel Aziz M ^a   Elsayed, Ahmed ^a   Smyth, Hugh D C ^b  

^a Mansoura University   (Egypt)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Alginate; Hydrogels; Nanoparticles; Oral drug delivery; Silymarin

Indexed keywords

AFM; ANALYTICAL TECHNIQUES; BIODEGRADABLE CARRIERS; DRYING METHODS; DRYING TECHNIQUE; FTIR; IN-VITRO; MICRO-PARTICLES; MOISTURE CONTENTS; NEW APPROACHES; ORAL DELIVERY; ORAL DRUG DELIVERY; PH VALUE; PH-RESPONSIVE; PH-RESPONSIVE HYDROGELS; POLY(D , L-LACTIC-CO-GLYCOLIC ACID); POLY(LACTIC-CO-GLYCOLIC ACID); SEM; SILYBUM MARIANUM; SILYMARIN; SODIUM ALGINATES; SUSTAINED RELEASE; SWELLING CHARACTERISTICS; UV- AND;

ALGINATE; BIOCHEMISTRY; BIODEGRADATION; CURING; DISSOLUTION; DRUG DELIVERY; DRYING; NANOPARTICLES; PLANTS (BOTANY); SODIUM; SWELLING;

HYDROGELS;

SILYBUM MARIANUM;

EID: 78650272586     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2010.09.055     Document Type: Article

References (36)

1. N. Barzaghi, F. Crema, G. Gatti, G. Pifferi, and E. Perucca Pharmacokinetic studies on IdB 1016, a silybin-phosphatidylcholine complex, in healthy human subjects European Journal of Drug Metabolism and Pharmacokinetics 15 1990 333 338
2. L. Baumann How to prevent photoaging Journal of Investigative Dermatology 125 2005 xii xiii
3. S. Beckmann-Knopp, S. Rietbrock, R. Weyhenmeyer, R.H. Böcker, K.T. Beckurts, and W. Lang Inhibitory effects of silibinin on cytochrome P-450 enzymes in human liver microsomes Pharmacology and Toxicology 86 2000 250 256 (Pubitemid 30413400)
4. E. Bombardelli, M. Spelta, Loggia, R. Della, S. Sosa, and A. Tubaro Aging skin: Protective effect of silymarin-phytosome Fitoterapia 62 1991 115 122
5. M.S. Cartiera, E.C. Ferreira, C. Caputo, M.E. Egan, M.J. Caplan, and M. Saltzman Partial correction of cystic fibrosis defects with PLGA nanoparticles encapsulating curcumin Molecular Pharmaceutics 7 2010 86 93
6. L.W. Chan, and P.W. Heng Effects of aldehydes and methods of cross-linking on properties of calcium alginate microspheres prepared by emulsification Biomaterials 23 2002 1319 1326
7. W. Chen, H. Xia, and W. Wu Optimized preparation of silymarin dripping pills by a central composite design-response surface method Chinese Traditional Herbal Drug 36 2005 679 683
8. I.M. El-Sherbiny Enhanced pH-responsive carrier system based on alginate and chemically modified carboxymethyl chitosan for oral delivery of protein drugs: Preparation and in vitro assessment Carbohydrate Polymers 80 2010 1125 1136
9. I.M. El-Sherbiny, E.M. Abdel-Bary, and D.R.K. Harding Preparation and in vitro evaluation of new pH-sensitive hydrogel beads for oral delivery of protein drugs Journal of Applied Polymer Science 115 2010 2828 2837
10. K. Flora, M. Hahn, H. Rosen, and K. Benner Milk thistle (Silybum marianum) for the therapy of liver disease The American Journal of Gastroenterology 93 1998 139 143 (Pubitemid 29063954)
11. J.M. Guenet Thermoreversible gelation of polymers and biopolymers 1992 Academic Press New York p. 89
12. S. Hirano, H. Tsuchida, and N. Nagao N-acetylation in chitosan and the rate of its enzymic hydrolysis Biomaterials 10 1989 574 576
13. D.H. Jeong, G.P. Lee, W.I. Jeong, S.H. Do, H.J. Yang, and D.W. Yuan Alterations of mast cells and TGF-beta1 on the silymarin treatment for CCl4-induced hepatic fibrosis World Journal of Gastroenterology 11 2005 1141 1148
14. R.A. Jain The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices Biomaterials 21 2000 2475 2490
15. J.D. Jia, M. Bauer, J.J. Cho, M. Ruehl, S. Milani, and G. Boigk Antifibrotic effect of silymarin in rat secondary biliary fobrosis is mediated by downregulation of procollagen alphal(I)and TIMP-1 Journal of Hepatology 35 2001 392 398 (Pubitemid 32844194)
16. J.S. Kang, Y.J. Jeon, S.K. Park, K.H. Yang, and H.M. Kim Protection against lipopolysaccharide-induced sepsis and inhibition of interleukin-1β and prostaglandin E2 synthesis by silymarin Biochemical Pharmacology 67 2004 175 181
17. N.C. Kim, T.N. Graf, C.M. Sparacino, M.C. Wani, and M.E. Wall Complete isolation and characterization of silybins and isosilybins from milk thistle (Silybum marianum) Organic Biomolecular Chemistry 1 2003 1684 1689
18. M. Lahiri-Chatterjee, S.K. Katiyar, R.R. Mohan, and R. Agarwal A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model Cancer Research 59 1999 622 632 (Pubitemid 29076060)
19. D.Z. Liu, W.P. Chen, C.P. Lee, S.L. Wu, Y.C. Wang, and T.W. Chung Effects of alginate coated on PLGA microspheres for delivery tetracycline hydrochloride to periodontal pockets Journal of Microencapsulation 21 2004 643 652
20. X. Liu, W.S.H. Paul, Q. Li, and L.W. Chan Novel polymeric microspheres containing norcantharidin for chemoembolization Journal of Controlled Release 116 2006 35 41 (Pubitemid 44792296)
21. S. Luper A review of plants used in the treatment of liver disease: Part 1 Alternative Medicine Review 3 1998 410 421 (Pubitemid 128709687)
22. 2-terminal kinase and janus kinase/signal transducer and activator of transcription pathways Endocrinology 146 2005 175 185 (Pubitemid 40051737)
23. P. Morazzoni, and E. Bombardelli Silybum marianum (Carduus marianus) Fitoterapia 46 1995 3 42
24. Y. Murata, Y. Kodama, T. Isobe, K. Kofuji, and S. Kawashima Drug release profile from calcium-induced alginate-phosphate composite gel beads International Journal of Polymer Science 2009 1 4
25. M.A. O'Hara, D. Kiefer, K. Farrell, and K. Kemper A review of 12 commonly used medicinal herbs Archives of Family Medicine 7 1998 523 536 (Pubitemid 128433264)
26. E. Ortega-Rivas Handling and processing of food powders and particulates C. Onwulata, Encapsulated and powdered foods 2005 CRC Press, Taylor & Francis G. Boca Raton 78 81
27. J. Pepping Milk thistle: Silybum marianum American Journal of Health-System Pharmacy 56 1999 1195 1197 (Pubitemid 29289776)
28. R. Schandalik, G. Gatti, and E. Perucca Pharmacokinetics of silybin in bile following administration of silipide and silymarin in cholecystectomy patients Arzneimittelforschung 42 1992 964 968
29. S.Y. Sheu, C.H. Lai, and H.C. Chiang Inhibition of xanthine oxidase by purpurogallin and silymarin group Anticancer Research 18 1998 263 267
30. J. Sonnenbichler, F. Scalera, I. Sonnenbichler, and R. Weyhenmeyer Stimulatory effects of silibinin and silicristin from the milk thistle Silybum marianum on kidney cells Journal of Pharmacology and Experimental Therapeutics 290 1999 1375 1383 (Pubitemid 29400283)
31. J. Sonnenbichler, and I. Zetl Biochemical effects of the flavanolignane silibinin on RNA, protein and DNA synthesis in rat livers V. Cody, E. Middleton, J.B. Harbourne, plant flavonoids in biology and medicine: Biochemical, pharmacological, and structure-activity relationships 1986 Alan, R. Liss New York 319
32. V.S. Trubetskoy Polymeric micelles as carriers of diagnostic agents Advanced Drug Delivery Reviews 37 1999 81 88 (Pubitemid 29164501)
33. W. Wu, Y. Wang, and L. Que Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system European Journal of Pharmaceutics and Biopharmaceutics 63 2006 288 294 (Pubitemid 43776222)
34. A. Zahoor, S. Sharma, and G.K. Khuller Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis International Journal of Antimicrobial Agents 26 2005 298 303 (Pubitemid 41338657)
35. X. Zi, D.K. Feyes, and R. Agarwal Anticarcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB 468: Induction of G1 arrest through an increase in Cip1/p21 concomitant with a decrease in kinase activity of cyclin-dependent kinases and associated cyclins Clinical Cancer Research 4 1998 1055 1064 (Pubitemid 28183409)
36. X. Zi, A.W. Grasso, H.J. Kung, and R. Agarwal A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells Cancer Research 58 1998 1920 1929 (Pubitemid 28217468)